price transparency
publication date
CFO
California Becomes Latest State To Try Capping Health Care Spending
California is the ninth state ? after Connecticut, Delaware, Massachusetts, Nevada, New Jersey, Oregon, Rhode Island, and Washington ? to...
Payer
Price Transparency: Private Plans Pay More, A Lot More
Left without cost data, a study shows employers are still struggling to create better health plans.
Technology
FTC Chief Says Tech Advancements Risk Healthcare Price Fixing
Algorithms make it possible for companies to fix prices without explicitly coordinating with one another.
CEO
New Federal Portal Urges Public to Report Healthcare Anticompetitive Practices
HealthyCompetition.gov is the latest effort by federal regulators to monitor the ongoing consolidation of the healthcare sector.
CEO
Northwell Health Dinged for $1M After 'Deceptively Advertising COVID-19 Testing Sites,' NY AG Says
New York's largest health system has refunded $400,000 to more than 2,000 patients, and will pay $650,000 in penalties to...
Payer
Biden Is Right About $35 Insulin Cap but Exaggerates Prior Costs for Medicare Enrollees
Insulin for Medicare beneficiaries 'was costing 400 bucks a month on average. It now costs $35 a month.' ? President...
Revenue Cycle
No Surprises Act Disputes Continue to Rise, Providers Blame Insurers
Over 288,000 disputes were submitted through the portal during the first six months of 2023.
Pharma
CMS Issues More Draft Guidance on Medicare Prescription Payment Plan
The initiative aims to reduce costly up-front, out-of-pocket prescription drugs costs for seniors.
Pharma
Patients See First Savings From Biden's Drug Price Push, as Pharma Lines Up Its Lawyers
The law represents the most significant overhaul for the U.S. drug marketplace in decades.
Pharma
HHS Opens Drug Price Dickering
With newfound authority granted by the IRA, HHS bids on 10 drugs selected for the first round of negotiations.
Pharma
Bernie Presses Big Pharma CEOs to Justify 'Outrageously High' U.S. Drug Prices
Senate HELP Committee mulls subpoenas if J&J, Merck CEOs refuse 'invitation' to testify.
CFO
Key Moves CFOs Must Make Amid Price Transparency and PBM Reform
A new bill may cause a shake-up for hospital and health systems.